State-owned Kiwibank will offer up to $150 million unsecured, subordinated bonds to the public to help fund its growth plans.
The debt sale will open on November 14 and close on December 5, formal offer documents reveal.
The debt sale offer opens just over a week after ratings agency Standard & Poor’s cut the credit ratings of Kiwibank and its parent, New Zealand Post, to A+ from AA-, citing the group's growing reliance on its banking operations and expectations of dwindling postal revenues.
The subordinated bonds have a maturity date of December 15, 2022, but may be called by Kiwibank from December 15, 2017, or earlier.
They will pay interest semi-annually for the first five years until December 15, 2017, at a rate to be set on November 13, following a bookbuild.
Kiwibank says it intends to treat the subordinated bonds as "tier 2" capital instruments under the Reserve Bank’s Basel III framework. The bonds are expected to have a credit rating of BB+ from Standard & Poor’s.
Investment statements are available from the joint lead managers or co-managers to the offer: Craigs Investment Partners, Kiwibank, ANZ, Forsyth Barr
Kiwibank had some $1.81 billion in issued debt securities as at June 30, according to its annual report.
This article is tagged with the following keywords. Find out more about MyNBR Tags
- NZ dollar gains as upbeat data across Asia spurs US dollar selling
- MARKET CLOSE: Shares rise as Trade Me gains, F&P reaches record; A2 Milk falls
- NZ house values rise at fastest pace in nine years
- Will Hellaby's lumpy contract oil and gas business finally deliver?
- RMA reform bill queue-jumps over legislative backlog
Most listened to
- Hellaby’s oil & gas services business could deliver this year, says new managing director Alan Clarke
- Hamish McNicol talks about Yoghurt Story
- TrueNet's John Butt on internet speeds
- Snakk Media chief executive Mark Ryan wonders how to "move the needle" on Snakk's share price
- Head-to-head: Federated Farmers director Katie Milne and SAFE executive director Hans kriek debate dairy industry's treatment of bobby calves